Today, drug firm Zydus Cadila has launched SoviHep, a generic version of Gilead Sciences' Hepatitis C drug Sofosbuvir, in India. A non-exclusive agreement between Zydus Cadila and Gilead Sciences will allow two things manufacturing and distribution.
As per the agreement, the manufacturing of sofosbuvir could be done and distribution of the fixed-dose combination of ledipasvir/sofosbuvir in 91 countries will also be permitted.
18:49 Marvel vs. Capcom: Infinite will pit Iron Man against Megaman X in 201711
14:07 Study: Believing in Santa Claus could be damaging to children16
12:43 Outgoing Starbucks CEO Howard Schultz: Kevin Johnson better prepared to be CEO13
13:01 Steven Mnuchin, Wilbur Ross Say Trump Will Pick Them as Treasury, Commerce Heads12